How should a patient with a type 1 Brugada electrocardiogram pattern be managed?

Management of Type 1 Brugada ECG Pattern

If the patient has a spontaneous type 1 Brugada pattern with cardiac arrest, sustained ventricular arrhythmia, or syncope presumed due to arrhythmia, implant an ICD; if asymptomatic with only an inducible type 1 pattern, observe without therapy. 1, 2

Risk-Based Management Algorithm

High-Risk Patients (ICD Recommended - Class I)

The following patients require ICD implantation if meaningful survival >1 year is expected 1, 2:

• Prior cardiac arrest survivors
• Sustained ventricular arrhythmia documented
• Recent syncope presumed due to ventricular arrhythmia

All three scenarios above require a spontaneous type 1 pattern (not just drug-induced) to meet Class I ICD indication.

Asymptomatic Patients (Observation - Class I)

Patients with only drug-inducible type 1 Brugada pattern should be observed without therapy 1, 2. This is a firm Class I recommendation with B-NR level of evidence.

Intermediate Risk Stratification (Controversial)

For asymptomatic patients with spontaneous type 1 pattern, the approach is more nuanced:

• Electrophysiologic study (EPS) may be considered for further risk stratification (Class IIb) 1, 2
• Research suggests that no single risk factor alone adequately identifies highest-risk patients 3
• Multiparametric approach combining syncope, family history of sudden death, and positive EPS identifies those at highest risk 3
• Patients with spontaneous type 1 ECG plus at least two risk factors (syncope, family history of sudden death, positive EPS) have substantially elevated risk, with event rates up to 30% in some cohorts 3

Critical caveat: The prognostic value of EPS remains debated. While some centers use positive EPS to justify ICD implantation, current guidelines assign only Class IIb indication for this approach 1, 2, 4. Research confirms that in clinical practice, EPS-based decisions may lead to overtreatment of low-risk individuals 4.

Alternative Therapies

For ICD-Ineligible or Declining Patients

Quinidine or catheter ablation is recommended (Class I) for patients with spontaneous type 1 pattern and symptomatic ventricular arrhythmia who cannot receive or decline ICD 1, 2.

For Recurrent ICD Shocks

Intensify therapy with quinidine or perform catheter ablation (Class I) in patients experiencing recurrent ICD shocks for polymorphic VT 1, 2. Recent evidence suggests epicardial ablation targeting the right ventricular outflow tract substrate may reduce VF recurrence significantly (HR 0.17), with time to benefit of only 0.2 months 5.

Diagnostic Confirmation

• Sodium channel blocker challenge (e.g., procainamide, ajmaline, flecainide) can be useful for diagnosis when spontaneous type 1 pattern is absent (Class IIa) 1, 2
• High precordial lead placement (V1-V2 at 2nd-3rd intercostal spaces) may unmask diagnostic patterns 6
• Only type 1 pattern is diagnostic; types 2 and 3 are not sufficient 6

Genetic Testing and Family Screening

Genetic counseling and testing may be useful to facilitate cascade screening of relatives (Class IIb, C-EO) 1, 2. However, genetic testing is not required for diagnosis or treatment decisions, as only ~20% have identifiable SCN5A mutations 6.

Essential Patient Counseling

All patients with confirmed Brugada pattern should:

• Avoid specific drugs (sodium channel blockers, certain antiarrhythmics, psychotropics)
• Promptly treat fever (hyperthermia can unmask arrhythmias)
• Undergo family screening of first-degree relatives
• Receive regular cardiology follow-up 6

Common Pitfalls

1. Do not confuse drug-induced with spontaneous patterns - only spontaneous type 1 warrants aggressive intervention
2. Syncope must be presumed arrhythmic - not all syncope in Brugada patients is high-risk
3. Avoid over-reliance on EPS alone for ICD decisions in asymptomatic patients 4
4. Distinguish from mimics: right bundle branch block, early repolarization, acute ischemia, ARVD 6